Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. V Zolota, A Gerokosta, M Melachrinou, A Kominea, C Aletra, CD Scopa Anticancer research 19 (4B), 3269-3274, 1999 | 649* | 1999 |
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology VK Anagnostou, FJ Lowery, V Zolota, V Tzelepi, A Gopinath, C Liceaga, ... BMC cancer 10, 1-11, 2010 | 90 | 2010 |
The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and … AC Tsamandas, D Kardamakis, P Tsiamalos, A Liava, V Tzelepi, ... Anticancer research 29 (2), 703-709, 2009 | 89 | 2009 |
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values G Cserni, A Vörös, I Liepniece-Karele, S Bianchi, V Vezzosi, D Grabau, ... The Breast 23 (3), 259-263, 2014 | 82 | 2014 |
Prognostic value of stromal tumor-infiltrating lymphocytes in young, node-negative, triple-negative breast cancer patients who did not receive (neo) adjuvant systemic therapy VMT de Jong, Y Wang, ND Ter Hoeve, M Opdam, N Stathonikos, ... Journal of Clinical Oncology 40 (21), 2361-2374, 2022 | 80 | 2022 |
Mammary tuberculosis mimicking breast cancer: a case report I Maroulis, C Spyropoulos, V Zolota, E Tzorakoleftherakis Journal of medical case reports 2, 1-4, 2008 | 77 | 2008 |
ILK expression in colorectal cancer is associated with EMT, cancer stem cell markers and chemoresistance D Tsoumas, S Nikou, E Giannopoulou, SC Tsaniras, C Sirinian, I Maroulis, ... Cancer genomics & proteomics 15 (2), 127-141, 2018 | 75 | 2018 |
Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents AA Argyriou, V Zolota, O Kyriakopoulou, HP Kalofonos J BUON 15 (3), 435-446, 2010 | 70 | 2010 |
Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study AC Tsamandas, K Thomopoulos, V Zolota, T Kourelis, T Karatzas, ... Modern pathology 16 (12), 1273-1288, 2003 | 64 | 2003 |
Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome V Zolota, AC Tsamandas, P Aroukatos, V Panagiotopoulos, T Maraziotis, ... Neuropathology 28 (1), 35-42, 2008 | 59 | 2008 |
The role of obesity in the immune response during sepsis AS Kolyva, V Zolota, D Mpatsoulis, G Skroubis, EE Solomou, IG Habeos, ... Nutrition & diabetes 4 (9), e137-e137, 2014 | 51 | 2014 |
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study M O’Loughlin, X Andreu, S Bianchi, E Chemielik, A Cordoba, G Cserni, ... Breast cancer research and treatment 171, 1-9, 2018 | 49 | 2018 |
Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient … Z Kefalopoulou, V Tzelepi, V Zolota, PD Grivas, C Christopoulos, ... Journal of neuro-oncology 106, 23-31, 2012 | 48 | 2012 |
The Potential Role of TGF [beta] 1, TGF [beta] 2 and TGF [beta] 3 Protein Expression in Colorectal Carcinomas AC Tsamandas, MD Dimitrios Kardamakis, P Ravazoula, V Zolota, ... Strahlentherapie und Onkologie 180 (4), 201, 2004 | 47 | 2004 |
Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients … V Zolota, C Sirinian, M Melachrinou, A Symeonidis, DS Bonikos Pathology-Research and Practice 203 (4), 199-207, 2007 | 45 | 2007 |
Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study AC Tsamandas, I Syrokosta, K Thomopoulos, V Zolota, D Dimitropoulou, ... Liver International 26 (7), 817-826, 2006 | 43 | 2006 |
Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study CD Scopa, AC Tsamandas, V Zolota, HP Kalofonos, A Batistatou, ... Digestive diseases and sciences 48, 1990-1997, 2003 | 43 | 2003 |
Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix V Zolota, V Tzelepi, Z Piperigkou, H Kourea, E Papakonstantinou, ... Cancers 13 (4), 713, 2021 | 41 | 2021 |
Prognostic significance of TGFβ-1 and pSmad2/3 in breast cancer patients with T1-2, N0 tumours D Koumoundourou, T Kassimatis, V Zolota, E Tzorakoeleftherakis, ... Anticancer research 27 (4C), 2613-2620, 2007 | 41 | 2007 |
Modulation of the Na+–H+ antiport activity by adrenaline on erythrocytes from normal and obese individuals D Bourikas, M Kaloyianni, M Bougoulia, Z Zolota, G Koliakos Molecular and cellular endocrinology 205 (1-2), 141-150, 2003 | 41 | 2003 |